Validation built on S-1 filings, not Reddit threads.

DimeADozen.AI: Sourced data + named comp-set + retention-curve math from public filings — not live-signal scrapers.

What you're actually getting

Every DimeADozen.AI validation report includes:

  • Market data

    Sourced from filings, regulatory data, and named industry reports. Not paraphrased; cited.

  • Named comp-set

    Three publicly-disclosed companies in your category. We name them. We pull their cohort-retention curves at month 3 / 6 / 12 / 24.

  • Retention-curve math

    Your projected retention plotted against the comp-set bell-curve. Three decision-classes: structurally optimistic, structurally pessimistic, or outside-bell-curve.

  • Risk taxonomy

    Six AI agents (research / market / financial / risk / competitor / synthesis) each scope a different failure-mode. Output is the consolidated synthesis with named risks and named mitigations.

  • Go/no-go read

    A structured downloadable PDF with the full agent-team reasoning chain. You can defend the decision to a co-founder, an investor, or your future self.

Depth vs breadth

Most validation tools scrape “live signals” — Reddit threads, Twitter sentiment, Crunchbase funding stages, Google Trends curves. That's breadth. We work from the cohort-comp-set data investors actually use:

Methodology dimensionCategory-typical AI validatorsDimeADozen.AI
Data sourceLive signal scraping (Reddit + Twitter + forums + funding DBs)Public S-1 filings + earnings reports + named comp-set economics
Output depthViability score + competitor map + risk flagsSourced data + named comp-set + S-1 retention curves + cohort unit-economics + structured go/no-go read
GranularitySurface signals (what people are saying)Cohort behavior (how comparable businesses actually performed)
Investor-readinessFounder-comfort gradeInvestor-grade depth
Pricing model$5–$29 per report + free-tier$129 once — pure validation specialist

$129 vs cheaper alternatives

$29 validation tools answer “what are people saying about my idea right now?” That's useful for founder-comfort.

$129 DimeADozen.AI answers “how have cohort-comparable businesses actually performed in their real customer retention curves and unit-economics?” That's investor-grade depth.

Both have a place. The question is which one you need at your stage.

  • If you're brainstorming: free-tier idea-score tools work. They scrape signals + give a temperature read.
  • If you're committing build-time: you need the depth. S-1 retention-curve math + named comp-set unit-economics show how comparable businesses actually retained their cohorts — the difference between “scoring 70+ on sentiment” and “scoring 70+ on cohort-economics.”
  • If you're going into a YC interview or fundraise: you need investor-grade depth. $129 once for the report; $499 Founder Strategy Call for the 1:1; $2K VC-Ready Diligence Pack for the deep pre-raise prep.

We publish the actual report shape

So you can audit it before paying.

Sample 1: Munchery autopsy

  • How a $100M+ funded company died on growth-stage retention math.
  • S-1 retention curve plotted against five comp-set meal-kit companies.
  • Risk taxonomy: liquid-cold-chain margin-floor, repeat-customer disambiguation, regulatory-contract dependency.
Read full Munchery autopsy →

Sample 2: Juicero autopsy

  • How a $100M+ funded company died on differentiated-hardware-ROI math.
  • S-1 retention curve plotted against three comp-set hardware-SaaS companies.
  • Risk taxonomy: hardware-margin-floor, competing-substitute-cost, distribution-channel concentration.
Read full Juicero autopsy →

Sourced data + named comp-set + retention-curve math is the work.

Not a chatbot to argue with.

Not a course to work through.

A structured downloadable decision document.

Pressure-test your own idea:

We’ve been mentioned in the press

CNBC Make itMetatextThe RundownTopAI.toolsOpenfuture

Get the DimeADozen newsletter

Bi-weekly. Two sections: What landed this week (a specific founder-validation decision) and Math you missed (a quantitative framework with named comp-set citations). Sourced research, not paraphrase.